Schizophrenia: all 3,539 studies
Page 27 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Body Movement Imitation and Perspective Perception Among Psychiatric PatientsStatus unknownNCT01375894Not applicable
- Multimodal MRI-guided rTMS to Treat Refractory HallucinationsCompletedNCT01373866Not applicable
- Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia PatientsStatus unknownNCT01370291Phase 3
- Brain Circuits in Schizophrenia and SmokingCompletedNCT01369966
- Conversion to Antipsychotic MonotherapyTerminatedNCT01368458Not applicable
- To Rescue Cognition With ValaciclovirCompletedNCT01364792Phase 2
- Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With SchizophreniaStatus unknownNCT01362478
- Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)CompletedNCT01362426
- Illness Management and Recovery (IMR) in Danish Community Mental Health CentresCompletedNCT01361698Not applicable
- Expanding Rapid Ascertainment Networks of Schizophrenia Families in TaiwanStatus unknownNCT01357005
- An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in SchizophreniaCompletedNCT01355952Not applicable
- Add On Treatment for Cognitive Deficits in SchizophreniaCompletedNCT01346163Phase 1
- PHARMO Institute Seroquel Safety StudyCompletedNCT01342120
- Benefits Management for People With Psychiatric DisabilitiesCompletedNCT01329393Phase 1
- Magnetoencephalographic (MEG) Evidence for Novel Metaphor Processing Among Schizophrenic PatientsCompletedNCT01325363Not applicable
- Web-Based Weight Management for Individuals With Mental IllnessCompletedNCT01324973Not applicable
- The Topical Niacin Skin Flush Test in First Episode PsychosisTerminatedNCT01324297
- Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With SchizophreniaStatus unknownNCT01324167
- Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With SchizophreniaCompletedNCT01323205Phase 2
- Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01320982Phase 3
- Effects of Cognitive Remediation Therapy on Schizophrenia Patients Through Functional Magnetic Resonance ImagingCompletedNCT01318850Not applicable
- Multi-site Communication Deficits in SchizophreniaCompletedNCT01317121
- Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in SchizophreniaStatus unknownNCT01315587Phase 2
- Dental Status of Patients With Severe Mental IllnessCompletedNCT01315509
- Feeling of Being in Control of One's Own ActionCompletedNCT01312649Not applicable
- Acute Psychological Effects of High Intensity Exercise With SchizophreniaCompletedNCT01310998Not applicable
- An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With SchizophreniaCompletedNCT01309373
- Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic PatientsStatus unknownNCT01300637Not applicable
- Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of SchizophreniaStatus unknownNCT01300364Phase 4
- Perception Processing in Schizophrenia Patients and Normal PopulationCompletedNCT01298349
- Morphological, Structural and Functional Neural Substrates of Quality of Life in SchizophreniaStatus unknownNCT01295411Not applicable
- Safety and Efficacy of Zicronapine in Patients With SchizophreniaCompletedNCT01295372Phase 3
- Adapted Cognitive/Affective Remediation for Cannabis Misuse in SchizophreniaCompletedNCT01292577Phase 1/2
- Improving Insight in Patients Diagnosed With SchizophreniaCompletedNCT01282307Not applicable
- Paliperidone Palmitate Flexible Dosing in SchizophreniaCompletedNCT01281527Phase 3
- Raloxifene in Treatment of Schizophrenia and Schizoaffective DisorderStatus unknownNCT01280305Phase 3
- Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant SchizophreniaCompletedNCT01279213Phase 4
- Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese SubjectsCompletedNCT01268124Phase 1
- Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in AdultsCompletedNCT01266174Phase 2
- Evaluation of Mirtazapine and Folic Acid for Schizophrenia:CompletedNCT01263080Phase 4
- Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With SchizophreniaStatus unknownNCT01260116
- The Imaging Genetic Study of Schizophrenia and FamilyStatus unknownNCT01259232
- A Study of Paliperidone Palmitate in Japanese Patients With SchizophreniaCompletedNCT01258920Phase 3
- GlyT-1 Inhibitor Treatment for Refractory SchizophreniaCompletedNCT01251055Phase 2
- Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)Status unknownNCT01250847Phase 4
- Expanding Rapid Ascertainment Network of Schizophrenia Families in TaiwanStatus unknownNCT01249079
- Optimization of Treatment and Management of Schizophrenia in EuropeCompletedNCT01248195Phase 4
- Amisulpride Augmentation in Clozapine-unresponsive SchizophreniaCompletedNCT01246232Phase 4
- Nicotinic Receptor Density in Smoking and Nonsmoking SchizophrenicsWithdrawnNCT01246128
- Relative Effectiveness of Schizophrenia Therapy StudyCompletedNCT01245348
- Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental IllnessCompletedNCT01244854Not applicable
- Pain and SchizophreniaTerminatedNCT01244542Not applicable
- Waist Circumference Measurements in Schizophrenic PatientsCompletedNCT01243034
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)CompletedNCT01235585Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)CompletedNCT01235559Phase 3
- A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)CompletedNCT01235520Phase 3
- A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of SchizophreniaCompletedNCT01234779Phase 2
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRICompletedNCT01234454Not applicable
- SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of SchizophreniaWithdrawnNCT01234298Phase 3
- Effects of Antipsychotics on Eating and Food Craving in People With SchizophreniaCompletedNCT01222793
- Multi-disciplinary Treatment for Patients Experiencing First Episode of PsychosisCompletedNCT01216891Not applicable
- The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic TherapyStatus unknownNCT01215383
- A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With SchizophreniaCompletedNCT01214135
- Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and ControlsCompletedNCT01214005Phase 2
- A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With SchizophreniaCompletedNCT01212575
- Assessment of Cannabis Craving in Schizophrenia Using Virtual RealityCompletedNCT01212081
- A Repeat Dose Positron Emission Tomography Study With GSK1144814CompletedNCT01209039Phase 1
- Social Cognition Training in SchizophreniaCompletedNCT01206842Not applicable
- Seroquel XR in the Long Term Treatment of SchizophreniaCompletedNCT01202617
- Effectiveness of Ziprasidone for Patients With SchizophreniaCompletedNCT01198353Phase 4
- Duration of Untreated Psychosis (DUP) and Pathways to Care in NordlandCompletedNCT01196858
- Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset PsychosisCompletedNCT01196286Not applicable
- Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalWithdrawnNCT01193166Phase 4
- A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)CompletedNCT01192906Phase 3
- A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of SchizophreniaCompletedNCT01192880Phase 3
- A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)CompletedNCT01192867Phase 3
- Milestones of Adjustment Post-PsychosisTerminatedNCT01192594Phase 3
- Add-On Therapy to Risperidonein SchizophreniaCompletedNCT01189006Phase 2/3
- The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic PatientsCompletedNCT01186471Early Phase 1
- Antipsychotics and Gene Expression in Soft TissuesCompletedNCT01185743Phase 4
- Reduction of Cardiovascular Risk in Severe Mental IllnessStatus unknownNCT01182012Phase 4
- Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health OrganizationsCompletedNCT01181960
- The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.CompletedNCT01181934Early Phase 1
- Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of SchizophreniaCompletedNCT01176721Phase 2
- Cognitive Remediation and Functional Skills Training in SchizophreniaCompletedNCT01175642Early Phase 1
- The Prevalence of Obesity For Schizophrenia Inpatients in TaiwanCompletedNCT01170689
- Study of Vitamin D in the Severely Mentally IllCompletedNCT01169142Phase 4
- Family Motivational Intervention in SchizophreniaStatus unknownNCT01167556Not applicable
- The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With SchizophreniaStatus unknownNCT01167348Not applicable
- The Effect of Ketamine on AttentivenessCompletedNCT01165294Phase 1
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaCompletedNCT01164059Phase 4
- Effect of AQW051 on Cognitive Function in Patients With Chronic Stable SchizophreniaCompletedNCT01163227Phase 2
- Effects of Aripiprazole and Haloperidol on Mesolimbic System FunctioningCompletedNCT01161277Phase 4
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose MetabolismCompletedNCT01160991Not applicable
- Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With SchizophreniaCompletedNCT01160679
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)CompletedNCT01154829Not applicable
- Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)CompletedNCT01150734
- A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With SchizophreniaCompletedNCT01150448Phase 1
- Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia PatientsCompletedNCT01149577Phase 4
- CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar IllnessCompletedNCT01149551